Treatment market is projected to grow from US$ 13650 million in 2024 to US$ 16110 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.8% during the forecast period.

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market

Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market

The global Chronic Obstructive Pulmonary Disease (COPD)

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Chronic Obstructive Pulmonary Disease (COPD) Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Chronic Obstructive Pulmonary Disease (COPD) Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Chronic Obstructive Pulmonary Disease (COPD) Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chronic Obstructive Pulmonary Disease (COPD) Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Chronic Obstructive Pulmonary Disease (COPD) Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report

Report Metric	Details
Report Name	Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Accounted market size in 2024	US$ 13650 million
Forecasted market size in 2030	US$ 16110 million
CAGR	2.8
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Corticosteroids Phosphodiesterase Type 4 Inhibitors Bronchodilators Others
Segment by Application	Hospital Clinic Retail Pharmacies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline, Novartis AG, Teva Pharmaceutical Industries, Sunovion Pharmaceuticals, CHIESI Farmaceutici, Orion Corporation, Mylan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Chronic Obstructive Pulmonary Disease (COPD) Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Obstructive Pulmonary Disease (COPD) Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Obstructive Pulmonary Disease (COPD) Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Chronic Obstructive Pulmonary Disease (COPD) Treatment Market growing?

Ans: The Chronic Obstructive Pulmonary Disease (COPD) Treatment Market witnessing a CAGR of 2.8 during the forecast period 2025-2030.

What is the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market size in 2030?

Ans: The Chronic Obstructive Pulmonary Disease (COPD) Treatment Market size in 2030 will be US$ 16110 million.

Who are the main players in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report?

Ans: The main players in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market are AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline, Novartis AG, Teva Pharmaceutical Industries, Sunovion Pharmaceuticals, CHIESI Farmaceutici, Orion Corporation, Mylan

What are the Application segmentation covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report?

Ans: The Applications covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report are Hospital, Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report?

Ans: The Types covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report are Corticosteroids, Phosphodiesterase Type 4 Inhibitors, Bronchodilators, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Corticosteroids

1.2.3 Phosphodiesterase Type 4 Inhibitors

1.2.4 Bronchodilators

1.2.5 Others

1.3 Market by Application

1.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Retail Pharmacies

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Perspective (2019-2030)

2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Trends by Region

2.2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Region (2019-2024)

2.2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Region (2025-2030)

2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Dynamics

2.3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Trends

2.3.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers

2.3.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges

2.3.4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Chronic Obstructive Pulmonary Disease (COPD) Treatment by Players

3.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Players (2019-2024)

3.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Chronic Obstructive Pulmonary Disease (COPD) Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio

3.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2023

3.5 Global Key Players of Chronic Obstructive Pulmonary Disease (COPD) Treatment Head office and Area Served

3.6 Global Key Players of Chronic Obstructive Pulmonary Disease (COPD) Treatment, Product and Application

3.7 Global Key Players of Chronic Obstructive Pulmonary Disease (COPD) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Type

4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Type (2019-2024)

4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2025-2030)

5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Application

5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Application (2019-2024)

5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

6.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type

6.2.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024)

6.2.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030)

6.2.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

6.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

6.3.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024)

6.3.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030)

6.3.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

6.4 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country

6.4.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024)

6.4.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

7.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type

7.2.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024)

7.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030)

7.2.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

7.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

7.3.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024)

7.3.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030)

7.3.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

7.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country

7.4.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024)

7.4.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

8.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type

8.2.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024)

8.2.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030)

8.2.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

8.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

8.3.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024)

8.3.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030)

8.3.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

9.2 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type

9.2.1 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024)

9.2.2 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030)

9.2.3 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

9.3 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

9.3.1 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024)

9.3.2 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030)

9.3.3 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

9.4 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region

9.4.1 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2019-2024)

9.4.3 Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.1.5 AstraZeneca Recent Developments

11.2 Boehringer Ingelheim International GmbH

11.2.1 Boehringer Ingelheim International GmbH Company Details

11.2.2 Boehringer Ingelheim International GmbH Business Overview

11.2.3 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.2.4 Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.2.5 Boehringer Ingelheim International GmbH Recent Developments

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.3.4 GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.3.5 GlaxoSmithKline Recent Developments

11.4 Novartis AG

11.4.1 Novartis AG Company Details

11.4.2 Novartis AG Business Overview

11.4.3 Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.4.4 Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.4.5 Novartis AG Recent Developments

11.5 Teva Pharmaceutical Industries

11.5.1 Teva Pharmaceutical Industries Company Details

11.5.2 Teva Pharmaceutical Industries Business Overview

11.5.3 Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.5.4 Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.5.5 Teva Pharmaceutical Industries Recent Developments

11.6 Sunovion Pharmaceuticals

11.6.1 Sunovion Pharmaceuticals Company Details

11.6.2 Sunovion Pharmaceuticals Business Overview

11.6.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.6.4 Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.6.5 Sunovion Pharmaceuticals Recent Developments

11.7 CHIESI Farmaceutici

11.7.1 CHIESI Farmaceutici Company Details

11.7.2 CHIESI Farmaceutici Business Overview

11.7.3 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.7.4 CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.7.5 CHIESI Farmaceutici Recent Developments

11.8 Orion Corporation

11.8.1 Orion Corporation Company Details

11.8.2 Orion Corporation Business Overview

11.8.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.8.4 Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.8.5 Orion Corporation Recent Developments

11.9 Mylan

11.9.1 Mylan Company Details

11.9.2 Mylan Business Overview

11.9.3 Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.9.4 Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.9.5 Mylan Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Boehringer Ingelheim International GmbH

GlaxoSmithKline PLC

Novartis

Teva Pharmaceutical Industries

Sunovion Pharmaceuticals

Chiesi Farmaceutici

Orion Corporation

Mylan NV

List of Tables

Table 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Corticosteroids

Table 3. Key Players of Phosphodiesterase Type 4 Inhibitors

Table 4. Key Players of Bronchodilators

Table 5. Key Players of Others

Table 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2019-2024)

Table 10. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2025-2030)

Table 12. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends

Table 13. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers

Table 14. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges

Table 15. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints

Table 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Share by Players (2019-2024)

Table 18. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2023)

Table 19. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Chronic Obstructive Pulmonary Disease (COPD) Treatment, Headquarters and Area Served

Table 22. Global Key Players of Chronic Obstructive Pulmonary Disease (COPD) Treatment, Product and Application

Table 23. Global Key Players of Chronic Obstructive Pulmonary Disease (COPD) Treatment, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2019-2024)

Table 27. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2025-2030)

Table 29. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Share by Application (2019-2024)

Table 31. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Share by Application (2025-2030)

Table 33. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 65. AstraZeneca Company Details

Table 66. AstraZeneca Business Overview

Table 67. AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 68. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 69. AstraZeneca Recent Developments

Table 70. Boehringer Ingelheim International GmbH Company Details

Table 71. Boehringer Ingelheim International GmbH Business Overview

Table 72. Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 73. Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 74. Boehringer Ingelheim International GmbH Recent Developments

Table 75. GlaxoSmithKline Company Details

Table 76. GlaxoSmithKline Business Overview

Table 77. GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 78. GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 79. GlaxoSmithKline Recent Developments

Table 80. Novartis AG Company Details

Table 81. Novartis AG Business Overview

Table 82. Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 83. Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 84. Novartis AG Recent Developments

Table 85. Teva Pharmaceutical Industries Company Details

Table 86. Teva Pharmaceutical Industries Business Overview

Table 87. Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 88. Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 89. Teva Pharmaceutical Industries Recent Developments

Table 90. Sunovion Pharmaceuticals Company Details

Table 91. Sunovion Pharmaceuticals Business Overview

Table 92. Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 93. Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 94. Sunovion Pharmaceuticals Recent Developments

Table 95. CHIESI Farmaceutici Company Details

Table 96. CHIESI Farmaceutici Business Overview

Table 97. CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 98. CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 99. CHIESI Farmaceutici Recent Developments

Table 100. Orion Corporation Company Details

Table 101. Orion Corporation Business Overview

Table 102. Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 103. Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 104. Orion Corporation Recent Developments

Table 105. Mylan Company Details

Table 106. Mylan Business Overview

Table 107. Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 108. Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 109. Mylan Recent Developments

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type: 2023 VS 2030

Figure 3. Corticosteroids Features

Figure 4. Phosphodiesterase Type 4 Inhibitors Features

Figure 5. Bronchodilators Features

Figure 6. Others Features

Figure 7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Other Case Studies

Figure 13. Chronic Obstructive Pulmonary Disease (COPD) Treatment Report Years Considered

Figure 14. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Players in 2023

Figure 18. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2023

Figure 20. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

Figure 22. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

Figure 23. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2019-2030)

Figure 24. United States Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

Figure 28. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

Figure 29. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2019-2030)

Figure 30. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

Figure 38. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

Figure 39. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

Figure 41. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

Figure 42. Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2019-2030)

Figure 43. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2019-2030)

Figure 53. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 60. Boehringer Ingelheim International GmbH Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 61. GlaxoSmithKline Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 62. Novartis AG Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 63. Teva Pharmaceutical Industries Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 64. Sunovion Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 65. CHIESI Farmaceutici Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 66. Orion Corporation Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 67. Mylan Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-33C941

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Respiratory Tract infections (RTIs) Treatment Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-6P6241

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Bronchiectasis Drugs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-2M6354

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Airway Endoscopes Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-1F7801

Thu Dec 19 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-33C941

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights, Forecast to 2030

FEATURED COMPANIES

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market

Scope of Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report

Chapter Outline

FAQ for this report

How fast is Chronic Obstructive Pulmonary Disease (COPD) Treatment Market growing?

What is the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market size in 2030?

Who are the main players in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report?

What are the Application segmentation covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report?

What are the Type segmentation covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS